Therefore, for IDH wild-type WHO grade 2–3 diffuse astrocytic glioma with low histological grade and consistent molecular characteristics of GBM, it is of extreme significance to obtain non-invasive and precise identification preoperatively. This evidence concerns the gene IDH2 and glioblastoma.